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The archetypical member of the small multidrug-resistance
family is EmrE, a multidrug transporter that extrudes toxic
polyaromatic cations from the cell coupled to the inward
movement of protons down a concentration gradient. The
architecture of EmrE was ﬁrst deﬁned from the analysis of
two-dimensional crystals by cryoelectron microscopy (cryo-
EM), which showed that EmrE was an unusual asymmetric
dimer formed from a bundle of eight -helices. The most
favoured interpretation of the structure was that the
monomers were oriented in opposite orientations in the
membrane in an antiparallel orientation. A model was
subsequently built based upon the cryo-EM data and
evolutionary constraints and this model was consistent with
mutagenic data indicating which amino-acid residues were
important for substrate binding and transport. Two X-ray
structures that differed signiﬁcantly from the cryo-EM
structure were subsequently retracted owing to a data-analysis
error. However, the revised X-ray structure with substrate
bound is extremely similar to the model built from the cryo-
EM structure (r.m.s.d. of 1.4 A ˚ ), suggesting that the proposed
antiparallel orientation of the monomersis indeed correct; this
represents a new structural paradigm in membrane-protein
structures. The vast majority of mutagenic and biochemical
data corroborate this structure, although cross-linking studies
and recent EPR data apparently support a model of EmrE
that contains parallel dimers.
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1. Introduction
EmrE from Escherichia coli is the archetypical small multi-
drug-resistance (SMR) transporter and has been extensively
studied using a multitude of techniques (Schuldiner et al.,
2001) since its initial characterization and the demonstration
of its role as a multidrug transporter (Yerushalmi et al., 1995).
However, over the last ﬁve years it has engendered consid-
erable debate for two main reasons. Firstly, two X-ray struc-
tures of EmrE (Ma & Chang, 2004; Pornillos et al., 2005) were
completely different (Tate, 2006) from the previously deter-
mined cryo-EM structure (Ubarretxena-Belandia et al., 2003);
both X-ray structures were subsequently retracted owing to a
data-handling error (Chang et al., 2006). Secondly, the
proposed arrangement of the monomers in the EmrE dimer in
an antiparallel orientation, as suggested by both the cryo-EM
(Ubarretxena-Belandia et al., 2003) and X-ray structures (Ma
& Chang, 2004; Pornillos et al., 2005), was contradicted by
biochemical and cross-linking studies (reviewed in Schuldiner,2007a,b). Together, these discrepancies have clouded the ﬁeld
and, with the publication of a third X-ray structure (Chen et
al., 2007), it is now appropriate to review the biophysical and
structural data and then discuss possible areas of conﬂict.
2. The oligomeric state of EmrE and the cryo-EM
structure
When EmrE is puriﬁed using the detergent dodecylmaltoside
(DDM), the resulting protein is able to bind the substrate
tetraphenylphosphonium (TPP
+)w i t haKd of 2 nM, which is
identical to the afﬁnity of unpuriﬁed EmrE for TPP
+ in E. coli
membranes (Tate et al., 2003). This suggests that the structure
of the substrate-binding pocket is unperturbed during puriﬁ-
cation and is indicative that the overall structure is also
unchanged. Sedimentation-equilibrium analytical ultracentri-
fugation (AUC) unambiguously showed that this puriﬁed
EmrE sample comprises a monomer and dimer in equilibrium,
with no indication of higher oligomeric states (Butler et al.,
2004). These data correlate with analysis by size-exclusion
chromatography (SEC) performed at 277 K, in which EmrE is
predominantly a dimer that dissociates only very slowly to the
monomer. Indeed, the dimer is remarkably stable in DDM and
incubation at 353 K for 15 min is required to dissociate DDM-
solubilized EmrE into monomers (Rotem et al., 2001). The
molar ratio of substrate binding to puriﬁed EmrE was deter-
mined to be one molecule of substrate per two molecules of
EmrE by saturation-binding experiments using
3H-TPP
+ and
is consistent with EmrE being a dimer in detergent (Butler et
al., 2004; Tate et al., 2003). Monomeric preparations of EmrE,
as determined by AUC, have also been produced by purifying
the protein in chloroform–methanol and resuspending the
dried-down protein in DDM (Winstone et al., 2005). It is
remarkable that many planar substrates such as ethidium bind
to this preparation with similar afﬁnities to dimeric EmrE,
presumably owing to the binding of the hydrophobic cations
to Glu14, which is in a hydrophobic environment; in contrast,
TPP
+ bound with an afﬁnity four orders of magnitude weaker
than for EmrE puriﬁed in DDM (Sikora & Turner, 2005),
indicating that monomeric EmrE is not in its native confor-
mation. That EmrE is a dimer in detergent solution and
represents the minimal functional unit for substrate binding is
therefore undisputed. However, it is still unclear whether
EmrE is a dimer in vivo or whether it forms a higher, perhaps
tetrameric, oligomeric state (Ubarretxena-Belandia & Tate,
2004); the only data addressing this issue are from a negative
dominance study suggesting that EmrE may form an oligomer
larger than a dimer (Yerushalmi et al., 1996).
The ﬁrst indications that the structure of EmrE was an
unusual asymmetric dimer came from its projection structure
determined by cryo-EM and image reconstruction of two-
dimensional crystals (Tate et al., 2001). TPP
+ bound to these
two-dimensional crystals with the same afﬁnity as to deter-
gent-solubilized EmrE and to unpuriﬁed EmrE in E. coli
membranes, so it is likely that the two-dimensional crystals
contained functional EmrE (Ubarretxena-Belandia & Tate,
2004). In fact, it was possible to elucidate that it was the EmrE
molecules within the crystalline lattice that bound the TPP
+
because there was a conformational change in the transporter
that caused disruption of the crystalline lattice and altered the
planar space group from c222 to p2 (Tate et al., 2003). Crystals
grown in the presence of TPP
+ also had a p2 lattice and a
comparison of the crystals grown in the absence or presence of
TPP
+ identiﬁed the site of TPP
+ binding as a region
surrounded by six of the eight helices forming the EmrE dimer
(Tate et al., 2003). The eight helices in the cryo-EM structure
were labelled A–H in an anticlockwise manner in the view
shown in Fig. 1(a) because it was not possible to assign the
amino-acid sequence to the corresponding density at 7.5 A ˚
resolution; in this nomenclature, the binding pocket is formed
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Figure 1
Structure of EmrE determined by cryo-EM at 7.5 A ˚ resolution. (a)A
view perpendicular to the membrane plane, with density contoured at 2
(red mesh) to which -helices were ﬁtted by eye. TPP
+ is represented by a
space-ﬁlling model. Half arrows represent the in-plane pseudo-twofold
axis that relates the two monomers. The superposition of helices A–D
onto helices H–E after rotation by 160  about the twofold axis is shown
from a side view (b) and top view (c). Reprinted from Tate (2006), with
permission from Elsevier.from helices A–B–C from one monomer and H–G–F from the
other. The TPP
+-binding pocket is also the site of binding of
three planar substrates, although EmrE binds these planar
substrates with a slightly different conformation from that of
the TPP
+ complex (Korkhov & Tate, 2008). Determination of
the three-dimensional structure of EmrE from the two-
dimensional crystals by cryo-EM conﬁrmed the presence of
density corresponding to TPP
+ in the centre of a binding
pocket bounded by six -helices (Fig. 1; Ubarretxena-
Belandia et al., 2003).
The cryo-EM structure of EmrE (Ubarretxena-Belandia et
al., 2003) has been called the ‘gold standard’ to which subse-
quent structures need to be compared (Rapp et al., 2007b) and
it is only the interpretation of the structure that has been
brought into question (Schuldiner, 2007b). Although the
assignment of the -helices to speciﬁc amino-acid sequences
was not possible, the striking presence of an in-plane pseudo-
twofold axis relating helices A–B–C to H–G–F by a 160 
rotation (Fig. 1) suggested the novel architecture consisting of
antiparallel dimers (Ubarretxena-Belandia et al., 2003; Tate,
2006). Indeed, even a brief consideration of possible models
for how two identical monomers can pack together, based on
our understanding of how transmembrane helices pack in
other membrane proteins, leads inexorably to the conclusion
that the most plausible model is composed of antiparallel
dimers (Fig. 2). This is because conserved residues, which in
membrane proteins point into the centre of the molecule to
make speciﬁc helix–helix and helix–substrate interactions, will
inevitably occur pointing towards the centre of the EmrE
dimer (Fig. 2). Biochemical evidence supports this, because
the highly conserved Glu14 residues from each monomer,
which are both essential for transport, have to be in the
binding pocket in close juxtaposition to perform substrate
transport (Koteiche et al., 2003; Muth & Schuldiner, 2000;
Rotem et al., 2001; Weinglass et al., 2005; Yerushalmi et al.,
2001; Yerushalmi & Schuldiner, 2000). A model containing
parallel monomers could in theory be possible, but completely
new concepts in protein structure have to be invoked to
explain it. The monomers in a parallel monomer model would
have to be related by a translation, followed by a rotation of
individual -helices through 180  about the helical axis to
place conserved residues in the centre of the dimer (Fig. 2).
The consequence of this is that the interfaces between adja-
cent helices within each monomer would be completely
different and would require the co-evolution of identical
amino-acid sequences to make two different packing inter-
faces with similar efﬁciencies; this has never previously been
found in any protein structure. In contrast, our understanding
of the determinants of membrane-protein topology (von
Heijne, 2006) offer ample precedent for a single membrane
protein inserting into the membrane in two opposing orien-
tations, both in vivo (Dunlop et al., 1995) and also from model
proteins with engineered topologies (Gafvelin & von Heijne,
1994). The fact that we do not understand fully the molecular
details of how a single membrane protein can be inserted into
the membrane in two different orientations does not in any
way detract from the fact of their existence.
3. The X-ray structures of EmrE
The ﬁrst two X-ray structures determined for EmrE (Ma &
Chang, 2004; Pornillos et al., 2005) did not correspond to the
cryo-EM structure and were both proposed to be non-native
(Tate, 2006); both X-ray structures had an incorrectly assumed
hand and were subsequently retracted (Chang et al., 2006).
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Figure 2
Theoretical considerations of how two identical monomers could be
arranged to form a dimer. In each of the panels the EmrE dimer is viewed
perpendicular to the membrane plane with each helix labelled 1–4 in a
different colour. The conserved faces of each helix are depicted as an arc
of black and the position of Glu14 is shown as a small purple sphere on
helix 1; biochemical data indicate that both Glu14 residues must be
closely juxtaposed. The relative topology of each monomer in the
membrane is depicted by either a plus (+) or a minus ( ) sign. The
relationship between monomer A and monomer B is considered in terms
of the transition required to go from A to B.( a) Parallel dimers related by
a translation; this is unlikely given that conserved residues in B are
oriented towards the lipid bilayer. (b) Parallel dimers related by
translation followed by 180  rotation of each helix about its axis
perpendicular to the membrane plane; this is unlikely given that the
interfaces between the helices in monomer A are different from the
helices in monomer B.( c) Parallel dimers related by a twofold axis
perpendicular to the membrane plane; this is unlikely given that the two
Glu14 residues are on opposite sides of the molecule. (d) Antiparallel
dimers related by an in-plane twofold axis (half arrows); this is likely
provided that the cell can synthesize a membrane protein with both
orientations in the membrane, i.e. dual topology.Recently, two revised structures have been published (Chen et
al., 2007). The structure of EmrE at pH 4.5 in the absence of
substrate (PDB code 3b61) is very similar to the original
structure and still represents a non-native state (Fig. 3).
However, the recalculated X-ray structure of EmrE with TPP
+
bound (PDB code 3b5d), including data from new crystals, ﬁts
extremely well into the density for the cryo-EM structure
(Chen et al., 2007). At 3.8 A ˚ resolution it was not possible to
build unambiguous models for the side chains, so only the C

coordinates have been deposited. Conﬁdence in the veracity
of the structure comes from clear densities for Se from the
MAD data sets used to obtain phases; it is particularly striking
that pairs of densities for the SeMet residues in the dimer are
entirely consistent with an antiparallel orientation of the
monomers (Fig. 3). In addition, a model derived from the
cryo-EM structure and evolutionary constraints (Fleishman et
al., 2006) has an r.m.s.d. of 1.4 A ˚ compared with the C
 posi-
tions in the revised X-ray structure (Fig. 3). Finally, all the
residues that have been predicted to be important in substrate
binding and translocation are within the substrate-binding
pocket delineated by the new X-ray structure (Chen et al.,
2007). Thus, there is now excellent agreement between the
cryo-EM model and the 3.8 A ˚ resolution structure derived
from X-ray crystallography, showing that EmrE is an anti-
parallel dimer.
The non-native pH 4.5 structure (Chen et al., 2007) is also
interesting as it may represent the minimal energy fold of
helices 1–3 immediately after synthesis in vivo, although in this
scenario helix 4 would adopt a mobile transbilayer orientation
rather than making contacts between neighbouring crystallo-
graphic tetramers as it does in the crystal. The extremely close
packing between the two helix 4s in the EmrE dimer suggests
that it may provide the major driving force for dimerization
and confer stability to the dimer during the conformational
changes in the transport cycle.
4. Studies of EmrE homologues
Members of the SMR family homologous to EmrE are found
widely throughout the bacterial world (Paulsen et al., 1996).
However, there are two different forms
in which the homologues occur in
bacteria. Firstly, a single gene can
produce a functional homodimer, as is
the case for E. coli EmrE (Yerushalmi et
al., 1995) and Smr from Staphylococcus
aureus (Grinius & Goldberg, 1994).
Secondly, a number of homologues are
composed of heterodimers (Jack et al.,
2000; Masaoka et al., 2000). The orien-
tation that a bacterial membrane pro-
tein adopts in the membrane can be
predicted with reasonable accuracy by
counting the number of Arg and Lys
residues on one side of a membrane
protein compared with the other; the
face that has the greatest number of
positively charged residues is on the
cytoplasmic face of the membrane (the
‘positive inside’ rule; von Heijne, 1986).
Comparisons of the charge distributions
in the two different groups of EmrE
homologues are extremely interesting
(Fig. 4). In the case of E. coli EmrE, the
distribution of Lys and Arg residues is
fairly even between the two hydrophilic
faces of the protein, which is in line with
the prediction that it could be oriented
in the membrane with dual topology, i.e.
some of the molecules have intracellular
N- and C-termini whilst others have
extracellular N- and C-termini; this
would be the case for the formation of
antiparallel dimers. In contrast, homo-
logues that are only functional as
heterodimers are composed of mono-
mers that have distinctive charge
research papers
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Figure 3
X-ray structures of EmrE. (a) The non-native structure of EmrE determined from crystals grown at
pH 4.5 viewed parallel to the membrane plane with the positions of Glu14 shown as space-ﬁlling
models and (b) the structure of one of the monomers viewed perpendicular to the membrane plane
in rainbow coloration (N-terminus blue, C-terminus red); the structures are from PDB entry 1s7b,
which has the same overall structure as the revised 3b61. (c) The corrected X-ray structure of EmrE
containing bound TPP
+ viewed parallel to the membrane plane (PDB code 3b5d). Electron density
corresponding to Se from MAD data is shown as either a red mesh or green mesh depending upon
the monomer in which the SeMet residues reside (numbered). The density corresponding to As in
the tetraphenylarsonium substrate is shown as a purple mesh. (d) Comparison between the model
based upon the cryo-EM structure and evolutionary constraints and the corrected X-ray structure.
(c) and (d) are reprinted with permission from Chen et al. (2007), (Copyright 2007, National
Academy of Sciences, USA).distributions, suggesting that each monomercan orient itself in
the membrane only in one orientation, as is normal for the
majority of membrane proteins. Each heterodimer is thus
formed of one protein with N- and C-termini in the cytoplasm
and one protein with N- and C-termini in the periplasm, i.e.
they form antiparallel dimers.
Is there experimental evidence supporting the topological
assignments predicted using the positive inside rule? The ﬁrst
clue to the abnormal topology of SMR proteins came from a
global topology analysis of 700 inner membrane proteins from
E. coli (Daley et al., 2005). This was performed by fusing two
topological reporters (GFP and PhoA) to the C-termini of all
the proteins and assaying for either GFP or PhoA activity; if
the C-terminus of the test protein normally resided in the
cytoplasm this would lead to high GFP activity and low PhoA
activity and vice versa for C-termini that resided in the peri-
plasm. The results for SMR proteinsdid not ﬁt this pattern and
the suggestion was raised that they could all have dual
topology (Rapp et al., 2006). This was tested for EmrE by an
elegant experiment that converted the normal EmrE homo-
dimer into a heterodimer composed of two monomers of
deﬁned topological orientation (Rapp et al., 2007a); this was
achieved by changing the number of positively charged resi-
dues on each face of the protein (Fig. 4). An in vivo assay for
EmrE activity showed that each of the modiﬁed monomers of
deﬁned topology were inactive when expressed alone, but
when they were expressed together normal EmrE activity was
restored. This experiment shows that only antiparallel dimers
are functional and that if EmrE monomers are all oriented in
the membrane in the same fashion then EmrE cannot func-
tion. The corollary experiment (Fig. 4) has also been per-
formed, in which a normally heterodimeric SMR family
member, EbrAB, was evolved to function as a homodimer by
removing the charge bias between the two faces of the protein
(Kikukawa et al., 2006). The topology of EbrAB was also
tested using a Cys-labelling strategy with Cys residues engi-
neered in the loops and at the N- and C-termini; all the
constructs giving normal rates of substrate transport were
found to adopt a topology predicted by the positive inside rule
(Kikukawa et al., 2007). In a concurrent series of experiments,
a Cys-labelling strategy was employed to probe the topology
of a series of EmrE mutants and the conclusion was that EmrE
adopted an antiparallel orientation in the membrane (Nara et
al., 2007). All these experiments suggest that the SMR
proteins tested to date function as antiparallel dimers.
5. Parallel versus antiparallel orientation of monomers
in EmrE
The structural studies on E. coli EmrE and the topology
studies mentioned above all seem to concur that the dimer is
composed of monomers arranged in an antiparallel fashion,
yet there are ﬁve papers to date that
conclude the opposite, i.e. that EmrE is
composed of monomers arranged in a
parallel fashion with the N- and
C-termini probably residing intracellu-
larly (reviewed in Schuldiner, 2007b).
The techniques that have been used in
these studies are varied and include
cross-linking (Soskine et al., 2002, 2006),
EPR (McHaourab et al., 2008), the
construction of genetically fused EmrE
holodimers (Steiner-Mordoch et al.,
2008) and topological studies using
labelling strategies and the accessibility
of tags to proteases (Ninio et al., 2004).
On the face of it, the use of multiple
biochemical techniques leading to an
apparently consistent conclusion is
rather compelling, but this is opposed
by equally compelling structural and
biochemical data concluding the exact
opposite. Can these views be reconciled
or are there commonalities in how
experiments were performed that could
give rise to erroneous conclusions?
Before trying to untangle this web of
experiments, it must be appreciated that
EmrE behaves abnormally compared
with other membrane proteins. This was
clear from the outset, where the ﬁrst
publication on the biochemistry of
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Figure 4
Orientation of SMR proteins in themembrane and experimental evidence for antiparallel dimers by
mutagenesis. (a) EmrE is proposed to be an antiparallel homodimer in the membrane. Mutagenesis
of positively charged residues (black circles) resulted in two genes expressing EmrE mutants with
deﬁned topology, either Cin or Cout. Neither monomer was active on its own, but co-expression
resulted in functionality (Rapp et al., 2007a). (b) EbrAB is a heterodimer that is only functional
when both genes are expressed. Mutagenesis of EbrA to equalize the positively charged residues
(black circles) on both faces of the membrane resulted in a functional homodimer (Kikukawa et al.,
2006).EmrE showed that it could be puriﬁed by extraction into
chloroform–methanol solution and then reconstituted back
into a functional form in proteoliposomes by drying it down in
the presence of excess lipids (Yerushalmi et al., 1995). This
methodology was adapted to prepare monomeric EmrE in
DDM (Winstone et al., 2005) which was able to bind planar
substrates with similar afﬁnities to native EmrE, but crucially
the high-afﬁnity substrate TPP
+ bound four orders of magni-
tude more weakly than to dimeric EmrE puriﬁed in DDM
using standard techniques in aqueous buffers (Sikora &
Turner, 2005). Thus, EmrE can exist in solution in a stable
non-native conformation in a mild detergent; this is unusual in
that most membrane proteins require harsh detergents such as
SDS to maintain a similarly misfolded state. What is even
more remarkable is that a non-native state of EmrE has
actually been crystallized and its structure has been deter-
mined (Chen et al., 2007). Normally, we assume that a
misfolded protein will exist in multiple conformations that
preclude crystallization, but apparently EmrE can exist
predominantly in a single non-native conformation. As
mentioned above, it is tempting to speculate that this non-
native state could represent a state of the monomer in the
membrane immediately after expression, with the ﬁnal
conformations of the monomer only being attained after
dimerization.
The peculiarities of EmrE may also extend to the over-
production of the protein for structural and biochemical
studies. If EmrE is indeed an antiparallel dimer, then its
synthesis is probably a delicate balance between the produc-
tion of the two orientations in the translocon which is based
upon the balance of positive charges on the two soluble faces
of the protein and the proton motive force present across the
cellular membrane in E. coli (von Heijne, 2006; White & von
Heijne, 2008). Anything that adversely affects either the
folding pathway for the polypeptides or the overall energy
balance of the cell could adversely affect the efﬁcient
production of EmrE. This is indeed what we have observed
and has been noted by others in the production of native
EmrE (Chen et al., 2007). Extensive efforts were made to show
that the puriﬁed EmrE used for the production of two-
dimensional crystals was in a native conformation and that the
EmrE in the two-dimensional lattice was also fully functional
(Butler et al., 2004; Tate et al., 2001, 2003; Ubarretxena-
Belandia & Tate, 2004); similar data have also now been
published for the production of EmrE for three-dimensional
crystallization (Chen et al., 2007).
What are the minimal data required to show that EmrE is
indeed in a native state? Two things have to be shown. Firstly,
that the afﬁnity of binding of substrates is in the same range as
for native EmrE in the membrane (Fig. 5). TPP
+ is a good
choice for this experiment because it is commercially available
in a tritiated form, it binds to native EmrE with high afﬁnity
and there is a clear difference in binding between native
(Kd ’ 2n M; Tate et al., 2003) and non-native EmrE
(Kd =2 5mM; Sikora & Turner, 2005). Moreover, assays can be
performed at high concentrations of TPP
+ (Butler et al., 2004)
to exclude the possibility that the puriﬁed EmrE contains a
small proportion of inactive protein. Binding assays
performed at a single ligand concentration are insufﬁcient
because this will not give any indication of the afﬁnity of
binding. Secondly, the amount of potentially misfolded EmrE
must be determined. For puriﬁed EmrE, this is trivial. The
Bmax from the saturation binding curve should equal half the
number of moles of EmrE in solution as determined by amino-
acid analysis (one
3H-TPP
+ binds per EmrE dimer). The molar
ratio of ligand bound to EmrE can also be determined from a
plot of ligand bound to EmrE versus the ligand concentration
(Fig. 5). The advantage of this methodology is that high
concentrations of EmrE can be used, which prevents any
dissociation of the dimer, and this method is compatible with
the use of either radioactive (Tate et al., 2003) or ﬂuorescent
ligands (Chen et al., 2007). If the EmrE sample is not puriﬁed,
then the amount of misfolded EmrE can be assessed by using a
dot-blotting technique (Zeder-Lutz et al., 2006). Here, the
research papers
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Figure 5
(a) Saturation binding curve of puriﬁed EmrE in detergent solution. Kd
values were determined by nonlinear regression using a single-site model
as indicated by the linearity of the Scatchard plot (inset). (b)
Determination of the ratio of TPP
+ binding to EmrE. The concentration
of EmrE in the experiment was determined by amino-acid analysis to be
80.5 mM and the intersection between the linear portions of the graph
occurs at a TPP
+ concentration of 40 mM. The negligible increase in
binding at 2.8 mM EmrE implies that there are no signiﬁcant amounts of
misfolded EmrE present in the puriﬁed sample. Reprinted from Tate et al.
(2003), with permission from Elsevier.total amount of tagged EmrE would be determined by
comparison of the signal developed between a sample and a
series of standards of known amounts of protein tagged with
the identical epitope.
However it is determined, the amount of misfolded EmrE
and the Kd for substrate binding of any EmrE sample has to be
assessed before any biochemical experiment can be correctly
evaluated. Unfortunately, this has never been determined in
any experiment proposing the presence of parallel EmrE
dimers. In some instances, Kd values for mutants have been
determined but the effect of the point mutations on the ability
of EmrE to fold efﬁciently has not been determined. As single
point mutations can dramatically reduce the amount of
protein expressed (Mordoch et al., 1999), there can clearly be
effects on the folding/stability of EmrE and the presence of
misfolded protein is a real concern. Clearly, if most (e.g. 90%)
of EmrE in a sample is incorrectly folded, then erroneous
results are inevitable regardless of how carefully the rest of the
experiments are performed. It is therefore entirely plausible
that the experiments implying the existence of parallel
monomers in the EmrE dimer are based on the topological
characterization of misfolded protein and not native EmrE.
We are grateful to R. Henderson for comments on the
manuscript and to G. Chang for providing high-resolution
images for Figs. 3(c)a n d3 ( d).
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